Martha, B., Croisier, D., Durand, D., Hocquet, D., Plesiat, P., Piroth, L., . . . Chavanet, P. (2006). In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin. Clinical Microbiology and Infection, 12, 426-432. https://doi.org/10.1111/j.1469-0691.2006.01371.x
Citace podle Chicago (17th ed.)Martha, B., D. Croisier, D. Durand, D. Hocquet, P. Plesiat, L. Piroth, Hugues Portier, a P. Chavanet. "In-vivo Impact of the MexXY Efflux System on Aminoglycoside Efficacy in an Experimental Model of Pseudomonas Aeruginosa Pneumonia Treated with Tobramycin." Clinical Microbiology and Infection 12 (2006): 426-432. https://doi.org/10.1111/j.1469-0691.2006.01371.x.
Citace podle MLA (9th ed.)Martha, B., et al. "In-vivo Impact of the MexXY Efflux System on Aminoglycoside Efficacy in an Experimental Model of Pseudomonas Aeruginosa Pneumonia Treated with Tobramycin." Clinical Microbiology and Infection, vol. 12, 2006, pp. 426-432, https://doi.org/10.1111/j.1469-0691.2006.01371.x.